EUVIMEDEUVIMED entdecken
Crossref

Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]

Adielle Abecassis, Laura Perray, Rafaele Molinier, Safa Idoudi, Helene Kemp, Céleste Lebbé, Laetitia Vercellino, Emilien Ezine, Marie Fournier

EJC Skin Cancer · 2026-03 · 100783

DOI: 10.1016/j.ejcskn.2026.100783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EJC Skin Cancer, 2026-03. Verfasst von Adielle Abecassis und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abecassis, A., Perray, L., Molinier, R., Idoudi, S., Kemp, H., Lebbé, C., Vercellino, L., Ezine, E., & Fournier, M. (2026). Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]. EJC Skin Cancer, 100783. https://doi.org/10.1016/j.ejcskn.2026.100783

Vancouver

Abecassis A, Perray L, Molinier R, Idoudi S, Kemp H, Lebbé C, et al. Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]. EJC Skin Cancer. 2026:100783. doi:10.1016/j.ejcskn.2026.100783

BibTeX
@article{Abecassis2026,
  author = {Abecassis, Adielle and Perray, Laura and Molinier, Rafaele and Idoudi, Safa and Kemp, Helene and Lebbé, Céleste and Vercellino, Laetitia and Ezine, Emilien and Fournier, Marie},
  title = {Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]},
  journal = {EJC Skin Cancer},
  year = {2026},
  pages = {100783},
  doi = {10.1016/j.ejcskn.2026.100783}
}
Kostenlos starten →